http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f190e519258c02fc53e0cb65c52adf62
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Wucherpfennig W. Wucherpfennig |
| name | Kai W Wucherpfennig Kai W. Wucherpfennig |
| given-name | Kai Kai W Kai W. |
| organization-name | From the Department of Adult Oncology and the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston; Department of Medicine, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston; Department of Environmental Health and Department of Pathology and Laboratory Medicine, Boston University School of Public Health; Zycos Inc, Lexington, MA; and the Department for Hematology and Oncology, University of Cologne, Germany. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts *Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA 02115; and; Neurology, Harvard Medical School, Boston, MA 02115 Center or Neurologic Disease, Division of Neurology, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115. From the *Department of Molecular Medicine, Children's Hospital, Boston, Massachusetts 02115; the ‡Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138; the §Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; and the ‖Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115; From the *Department of Molecular Medicine, Children's Hospital, Boston, Massachusetts 02115; the ‡Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138; the §Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; and the ‖Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115 ‡Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, MA 02115 Dana Farber Cancer Institute Boston MA 02215 USA 6Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. †Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Neurology, Harvard Medical School, Boston, MA 02115; and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,; †Program in Immunology and From the *Neurological Diseases Section, Neuroimmunology Branch, and the ‡Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892; the §Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, Maryland 20814; and the ‖Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 ∥Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Pathology and Department of Neurology, Harvard Medical School, Boston, MA 02115 Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, and Department of Microbiology and Molecular Biology, Howard Hughes Medical Institute, Tufts University, School of Medicine, Boston, Massachusetts 02111 Center for Neurologic Diseases, Brigham and Women's Hospital, and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Neurology, Harvard Medical School, Boston, MA 02115; School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, United Kingdom; and Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 From the Department of Adult Oncology and the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School; and the Department of Medicine, Brigham and Women's Hospital, Boston, MA. †Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 , and 2; Program in Immunology, Harvard Medical School, Boston, MA 02115 1 , and 2; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 , and 2; Program in Immunology, Harvard Medical School, Boston, MA 02115 1 , and 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 , and 2; Program in Immunology, Harvard Medical School, Boston, MA 02215 1 , and 2; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 , and 2; Program in Immunology, Harvard Medical School, Boston, MA 02215 1 , and 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Neurology, Harvard Medical School, Boston, MA 02115 *Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston MA 02115;; #Department of Neurology and; **Program in Immunology, Harvard Medical School, Boston, MA 02115 2Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 7Department of Immunology, Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute; †Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115 *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115; and; ‡Program in Immunology, and; §Department of Neurology, Harvard Medical School, Boston, MA 02115 Department of Cancer Immunology and Virology, Dana–Farber Cancer Institute, Boston, MA 02215; ‡Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and; §Department of Neurology, Harvard Medical School, Boston, MA 02115 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts. *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115;; ‡Department of Neurology,; §Program in Immunology, Harvard Medical School, Boston, MA 02115; 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Immunology, Harvard Medical School, Boston, Massachusetts.; 6Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 ; and 2; Program in Immunology, Harvard Medical School, Boston, MA 02115 1 ; and 2; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute 1 ; and 2; Program in Immunology, Harvard Medical School, Boston, MA 02115 1 ; and 2 From the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and; †Department of Neurology, Harvard Medical School, Boston, MA 02115 ‡Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115; and Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA 02115; and Program in Immunology and Department of Neurology, Harvard Medical School, Boston, MA 02115 ‡Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115 Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;; Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, USA; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA *Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, and; †Department of Neurology, Harvard Medical School, Boston, MA 02115 ‡Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, and Department of Neurology, Harvard Medical School, Boston, MA 02115 ‡Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute;; ∥Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute, Boston, MA 02115 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Immunology, Harvard Medical School, Boston, Massachusetts.; 6Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Cancer Immunology & AIDS, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Neurology, Harvard Medical School, Boston, MA 02115; Department of Molecular Medicine, Children’s Hospital, Boston, MA 02115; and Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 3Harvard Medical School, Boston, Massachusetts. *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115; *Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Departments of; ‡ Neurology, Harvard Medical School, Boston, MA 02115 Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts |
Incoming Links
Total number of triples: 228.